Search Results - "MUNAR, Myrna Y"

Refine Results
  1. 1
  2. 2

    Aprepitant Pharmacokinetics and Assessing the Impact of Aprepitant on Cyclophosphamide Metabolism in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation by Bubalo, Joseph S., Cherala, Ganesh, McCune, Jeannine S., Munar, Myrna Y., Tse, Sunny, Maziarz, Richard

    Published in Journal of clinical pharmacology (01-04-2012)
    “…Aprepitant, a neurokinin antagonist, is an effective antiemetic agent in chemotherapy for delayed nausea and vomiting. The study objective was to evaluate the…”
    Get full text
    Journal Article
  3. 3

    Daptomycin Pharmacokinetics in Adult Oncology Patients with Neutropenic Fever by BUBALO, Joseph S, MUNAR, Myrna Y, CHERALA, Ganesh, HAYES-LATTIN, Brandon, MAZIARZ, Richard

    Published in Antimicrobial Agents and Chemotherapy (01-02-2009)
    “…ERRATUM ( vol. 53 , p. 3179 ) Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg…”
    Get full text
    Journal Article
  4. 4

    Are children undergoing cardiac surgery receiving antibiotics at subtherapeutic levels? by Huang, Jennifer H., MD, Sunstrom, Rachel, PA, Munar, Myrna Y., PharmD, Cherala, Ganesh, PhD, Legg, Arthur, MD, Olyeai, Ali J., PharmD, Langley, Stephen M., MD, FRCS (CTh)

    “…Objectives Perioperative antibiotics have decreased—but not eradicated—postoperative infections. In patients undergoing cardiac surgery with cardiopulmonary…”
    Get full text
    Journal Article
  5. 5

    Drug dosing adjustments in patients with chronic kidney disease by Munar, Myrna Y, Singh, Harleen

    Published in American family physician (15-05-2007)
    “…Chronic kidney disease affects renal drug elimination and other pharmacokinetic processes involved in drug disposition (e.g., absorption, drug distribution,…”
    Get full text
    Journal Article
  6. 6

    Intravenous Versus Intraosseous Use of Tranexamic Acid in Patients With Traumatic Brain Injury by Newman, Zachary C., Ogbeifun, Victoria O., Barbosa, Claire E., McKinley, W. Ian, Benjamin, Andrew J., Munar, Myrna Y., Pramuka, Pierce E., McGovern, Katie D., Nordgren, Rachel K., Schreiber, Martin A., Rowell, Susan E.

    Published in The Journal of surgical research (01-10-2024)
    “…Tranexamic acid (TXA) is an antifibrinolytic drug that has been demonstrated to reduce head injury–related mortality when given within 2 h of injury in…”
    Get full text
    Journal Article
  7. 7

    Administration of Tobramycin in the Beginning of the Hemodialysis Session: A Novel Intradialytic Dosing Regimen by Kamel Mohamed, Osama Hussein, Wahba, Ihab M, Watnick, Suzanne, Earle, Sandra B, Bennett, William M, Ayres, James W, Munar, Myrna Y

    “…Aminoglycoside antibiotic efficacy is related to peak concentration (C(max)) and postantibiotic effect, whereas toxicity is directly related to body exposure…”
    Get full text
    Journal Article
  8. 8

    Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial by Edelman, Alison B, Cherala, Ganesh, Munar, Myrna Y, McInnis, Martha, Stanczyk, Frank Z, Jensen, Jeffrey T

    Published in Contraception (Stoneham) (01-11-2014)
    “…Abstract Objective To determine if increasing the hormone dose or eliminating the hormone-free interval improves key pharmacokinetic (PK) alterations caused by…”
    Get full text
    Journal Article
  9. 9

    Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity by Edelman, Alison B, Carlson, Nichole E, Cherala, Ganesh, Munar, Myrna Y, Stouffer, Richard L, Cameron, Judy L, Stanczyk, Frank Z, Jensen, Jeffrey T

    Published in Contraception (Stoneham) (01-08-2009)
    “…Abstract Background This study was conducted to determine whether increased body mass index (BMI) affects oral contraceptive (OC) pharmacokinetics and…”
    Get full text
    Journal Article
  10. 10

    Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users by Edelman, Alison B, Cherala, Ganesh, Munar, Myrna Y, DuBois, Barent, McInnis, Martha, Stanczyk, Frank Z, Jensen, Jeffrey T

    Published in Contraception (Stoneham) (01-02-2013)
    “…Abstract Background Pharmacokinetic (PK) parameters based on short sampling times (48 h or less) may contain inaccuracies due to their dependency on…”
    Get full text
    Journal Article
  11. 11

    Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters by Yadav, Vijayshree, Marracci, Gail H, Munar, Myrna Y, Cherala, Ganesh, Stuber, Lauren E, Alvarez, Lilia, Shinto, Lynne, Koop, Dennis R, Bourdette, Dennis N

    Published in Multiple sclerosis (01-04-2010)
    “…Lipoic acid is a natural anti-oxidant available as an oral supplement from a number of different manufacturers. Lipoic acid administered subcutaneously is an…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    The use of wireless laptop computers for computer-assisted learning in pharmacokinetics by Munar, Myrna Y, Singh, Harleen, Belle, Donna, Brackett, Carolyn C, Earle, Sandra B

    “…To implement computer-assisted learning workshops into pharmacokinetics courses in a doctor of pharmacy (PharmD) program. Workshops were designed for students…”
    Get full text
    Journal Article
  15. 15

    Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients by Brunner, Lane J., Pai, Ki-Soo, Munar, Myrna Y., Lande, Marc B., Olyaei, Ali J., Mowry, Jeanne A.

    Published in Pediatric transplantation (01-11-2000)
    “…: Cyclosporin A (CsA) is an important immunosuppressant that is prone to numerous drug interactions. Grapefruit juice has been investigated, as a possible…”
    Get full text
    Journal Article
  16. 16

    Student pharmacists' perspectives on health equity following a co‐curricular activity by Irwin, Adriane N., Munar, Myrna Y., Olstad, Stacey, Braden‐Suchy, Natalea

    “…Introduction Increasing awareness of the social determinants of health and their effect on health disparities is essential to developing clinicians prepared to…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    The Use of Wireless Laptop Computers for Computer-Assisted Learning in Pharmacokinetics by Munar, Myrna Y, Singh, Harleen, Belle, Donna, Brackett, Carolyn C, Earle, Sandra B

    “…To implement computer-assisted learning workshops into pharmacokinetics courses in a doctor of pharmacy (PharmD) program. Workshops were designed for students…”
    Get full text
    Journal Article
  20. 20

    Meropenem pharmacokinetics in a patient with multiorgan failure from meningococcemia undergoing continuous venovenous hemodiafiltration by Meyer, Mary M., Munar, Myrna Y., Kohlhepp, Sue J., Bryant, Richard E.

    Published in American journal of kidney diseases (01-04-1999)
    “…Meropenem is a carbapenem antibiotic with a broad antibacterial spectrum of activity. Its main route of elimination is through the kidneys, with 63% of the…”
    Get full text
    Journal Article Conference Proceeding